[USA] Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced that its President, Mawae Morton, has been named as Chief Executive Officer and a Director of the company, effective January 24, 2018.
Mr. Morton replaces Founder and interim CEO, Dr. Gerry Cysewski, who will return to his role of Chief Scientific Officer and become Vice Chairman of the Board of Directors of the company. Dr. Cysewski is recognized as a leading authority on large-scale production of microalgae and is a frequently invited speaker at industry gatherings around the world.
A special committee of Cyanotech’s Board of Directors led an extensive search for a permanent CEO, which resulted in Mawae Morton’s appointment as President in July 2017. In welcoming him to the CEO role and the Board, Cyanotech Chairman Michael Davis, stated, “We are pleased to have someone with Mawae’s business experience and look forward to his perspective as a leader who can leverage our company’s assets and leadership team to drive the next stage of Cyanotech’s growth. Mawae has provided excellent leadership as President of Cyanotech, and we know that will continue as he steps into the role of CEO.”
Mr. Morton has a deep understanding of complex bio-based operating businesses from various executive positions in the bio-refinery and agriculture disciplines. He previously served as Chief Executive Officer of HBE BiorefineryCo, a Hawaii-based forestry and bioenergy development company.
“This is an exciting time for Cyanotech. I am eager to take on the opportunities that lie ahead,” Mr. Morton said. “As Cyanotech continues to enhance its brand and category recognition as a world leader in natural, high-quality astaxanthin and spirulina products, there are significant growth opportunities for the company in the future.”
View original article at: Cyanotech names Mawae Morton as Chief Executive Officer and a member of the board of Directors